Neurizon Therapeutics Ltd

NUZ

Company Profile

  • Business description

    Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

  • Contact

    96-100 Albert Road
    Level 4
    South Melbourne
    MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.neurizon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    52

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,688.0035.50-0.41%
CAC 407,565.5724.09-0.32%
DAX 4023,320.0130.54-0.13%
Dow JONES (US)42,206.8235.160.08%
FTSE 1008,762.4012.25-0.14%
HKSE23,659.74129.260.55%
NASDAQ19,447.4198.86-0.51%
Nikkei 22538,354.0949.14-0.13%
NZX 50 Index12,532.6536.40-0.29%
S&P 5005,967.8413.03-0.22%
S&P/ASX 2008,474.9030.60-0.36%
SSE Composite Index3,381.5821.690.65%

Market Movers